Display options
Share it on

Eur Urol. 2007 Sep;52(3):918-9. doi: 10.1016/j.eururo.2007.06.011.

Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.

European urology

Tom F Lue, Anthony J Bella

Affiliations

  1. Department of Urology, University of California, San Francisco, San Francisco, CA, USA.

PMID: 17855853 DOI: 10.1016/j.eururo.2007.06.011

[No abstract available.]

Publication Types